Medicare Enrolled

Dr. Brad Glick, MD

Dermatology · Margate, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
3275 NORTH STATE ROAD 7, Margate, FL 33063
9549743664
In practice since 2005 (20 years)
NPI: 1235134818 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Glick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glick? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Glick

Dr. Brad Glick is a dermatology in Margate, FL, with 20 years in practice. Based on federal Medicare data, Dr. Glick performed 11,883 Medicare services across 5,342 unique beneficiaries.

Between the years covered by Open Payments, Dr. Glick received a total of $1,851,172 from 58 pharmaceutical and/or device companies across 2177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Glick is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in FL$ $1,851,172 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,883
Medicare services
Top 11% in FL for dermatology
5,342
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~594 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-145,173$5$35
Office visit, established patient (20-29 min)2,086$66$150
Destruction of precancerous skin growth, 11,537$41$125
Skin biopsy, tangential800$75$225
Office visit, established patient (30-39 min)716$92$200
Biopsy of related skin growth, each additional growth243$41$100
Destruction of precancer skin growth, 15 or more growths205$133$550
Steroid injection (triamcinolone)203$1$10
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm104$137$299
New patient office visit (30-44 min)85$78$200
Injection into skin growth, 1-7 growths81$31$100
Drug injection, under skin or into muscle66$10$30
Punch biopsy, first skin growth53$100$202
New patient office visit (45-59 min)50$127$275
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm48$140$350
Biopsy of ear47$57$200
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm41$149$400
Office visit, established patient (10-19 min)37$40$125
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm31$106$250
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm31$154$375
Punch biopsy, each additional skin growth29$49$100
Destruction of skin growths (warts/lesions), 1-1429$82$175
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm22$339$700
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm22$165$450
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm21$236$425
Complicated repair of wound of trunk, 2.6-7.5 cm18$310$700
Biopsy of lip18$95$250
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm16$181$450
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm16$119$325
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)16$307$550
Application of light by qualified health care professional to destroy precancer skin growth14$169$325
Injection into skin growth, more than 7 growths13$44$125
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm12$145$375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,851,172
Total received (2018-2024)
Avg $264,453/year across 7 years
Top 0% in FL for dermatology
58
Companies
2,177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,723,514 (93.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$120,700 (6.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,957 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$360,947
2023
$367,022
2022
$321,955
2021
$197,748
2020
$155,309
2019
$213,551
2018
$234,641

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$181,888
UCB, Inc.
$146,874
Amgen Inc.
$141,654
Janssen Scientific Affairs, LLC
$140,107
ABBVIE INC.
$137,309
Regeneron Healthcare Solutions, Inc.
$136,358
E.R. Squibb & Sons, L.L.C.
$92,193
Janssen Biotech, Inc.
$89,944
Incyte Corporation
$76,780
Novartis Pharmaceuticals Corporation
$76,015
Sun Pharmaceutical Industries Inc.
$69,985
Boehringer Ingelheim Pharmaceuticals, Inc.
$67,022
GENZYME CORPORATION
$58,377
AbbVie, Inc.
$57,359
Ortho Dermatologics, a division of Bausch Health US, LLC
$53,793
Dermavant Sciences, Inc.
$53,526
PFIZER INC.
$48,314
Celgene Corporation
$48,244
Arcutis Biotherapeutics, Inc.
$44,753
AbbVie Inc.
$39,752
Eli Lilly and Company
$24,501
SUN PHARMACEUTICAL INDUSTRIES INC.
$15,492
Hikma Pharmaceuticals USA
$11,500
EPI Health, LLC
$5,564
Sensus Healthcare, Inc.
$5,500
DERMIRA, INC.
$5,471
LEO Pharma Inc.
$4,734
Almirall LLC
$4,630
Pfizer Inc.
$4,414
NOVARTIS PHARMACEUTICALS CORPORATION
$2,800
Galderma Laboratories, L.P.
$2,665
Regeneron Pharmaceuticals, Inc.
$591
Verrica Pharmaceuticals Inc.
$429
Journey Medical Corporation
$405
Mayne Pharma Inc.
$330
Biofrontera Inc.
$264
Merz North America, Inc.
$224
SANOFI-AVENTIS U.S. LLC
$223
Promius Pharma LLC
$139
Genentech USA, Inc.
$137
VYNE Pharmaceuticals Inc.
$111
Janssen Research & Development, LLC
$105
Paratek Pharmaceuticals, Inc.
$102
Encore Dermatology Inc.
$94
Merck Sharp & Dohme Corporation
$69
STRATA Skin Sciences, Inc.
$61
PruGen, Inc. Pharmaceuticals
$47
Smith+Nephew, Inc.
$45
Organogenesis Inc.
$45
Aclaris Therapeutics, Inc.
$38
DUSA Pharmaceuticals, Inc.
$37
Helsinn Therapeutics (U.S.), Inc.
$36
Allergan, Inc.
$36
MAYNE PHARMA INC.
$26
Pierre Fabre Pharmaceuticals, Inc.
$21
Mylan Pharmaceuticals Inc.
$16
Misonix Inc
$11
Glenmark Therapeutics Inc.
$10
Top 3 companies account for 25.4% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Ameluz · BLU-U · BOTOX · BRYHALI · Bimzelx · CIBINQO · CLODERM · COLLAGENASE SANTYL · COSENTYX · CYLTEZO · Ceracade · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cloderm Cream · DERMATITIS - DISEASE · DISEASE STATE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · ENSTILAR · EUCRISA · Enbrel · Erivedge · Exelderm · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · NUZYRA · Neupro · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Olumiant · Otezla · Otiprio · Puraply · QBREXZA · REMICADE · RETIN-A · RHOFADE · RINVOQ · SILIQ · SIMPONI ARIA · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Veltin · WYNZORA · Winlevi · XOLAIR · XTRAC · YCANTH · ZEPBOUND · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for dermatology in FL.

Equivalent to $15,578 per 100 Medicare services performed
Looking for a dermatology in Margate?
Compare dermatologys in the Margate area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
229
Per 100K population
11.8
County median income
$74,534
Nearest hospital
HCA FLORIDA NORTHWEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Glick is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and high industry engagement (speaking/promotional, top 0%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Glick experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Glick performed 5,173 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glick receive payments from pharmaceutical companies?
Yes. Dr. Glick received a total of $1,851,172 from 58 companies across 2,177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glick's costs compare to other dermatologys in Margate?
Dr. Glick's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →